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What is Bioprospecting in Relation to CAM?
With Volume 2 of eCAM, we begin to intensify the inclusion
of complementary and alternative medicine (CAM)-related
natural products derived from plants and from animals (1).
There will be an attempt to focus on products from animals,
since we know that the literature tends to be ‘glutted’ with
products derived from plants (1,2). In either case, both sources
of natural products provide a veritable cornucopia of sources
of new CAM approaches that will emerge as important for
future applications, including compounds isolated from marine
microorganisms and phytoplankton, green algae, brown algae,
red algae, fungi and certain well-known marine and terrestrial
animals: sponges, coelenterates, bryozoans, molluscs, tuni-
cates, echinoderms, earthworms and leeches (3,4). Very
briefly, there has been an emphasis on new compounds (677 in
2002), together with their relevant biological activities, source
organisms and country of origin. As a result, syntheses that
lead to the revision of structures or stereochemistries have
been included (114), including any first total syntheses of a
marine natural product (5).
The prefix bio of course signifies life, and prospecting is
defined in several ways: ‘an extensive view of a landscape, a
mental view of matters; an expectation, a possibility; a chance
of success or advancement; a possible customer or client; to
explore in search of something.’When put together, they fit the
kinds of searches that will be explored in eCAM. Actually
Muller has recently legitimized the terminology, and our rapid
grasp of this possibility is now being rigorously exploited for
the good of CAM (6,7)—a kind of resurrection of approaches
used to define antibiotics and anticancer molecules (8). Because
the literature concerning plants (herbals) is well documented
(crowded and found in diverse journals), and because of space,
this editorial will focus on a few selected examples of products
from one particular animal group. This tack highlights the
growing importance of a seemingly new area of work. In fact,
many of these investigations are not new, but it is their reori-
entation toward more practical concerns that has driven this
quest away from the search for the sake of the exotic animals
themselves. Many of us, the new prospectors, began as biologists,
comparative immunologists and invertebrate immunologists
(8–10). Eureka in the words of Archimedes! Not about the
physical principle concerning water, but about the existence of
applicability of molecules derived from invertebrate immune
systems! Clearly this firm grounding in biology and the result-
ing amalgam with immunology will lie at the forefront of
efforts to bolster the pursuit or attempts at bioprospecting.
Organismic Benefits of Bioprospecting
The first objective in a serious approach to CAM should be to
obtain a broad understanding, with a minimum of detail, of
how CAM fits into the pattern of biology—of the way in which
the neuroendocrine immune system evolved, its function and
coordination with other body systems, and its development
from the embryo onwards (11,12). At the same time, such an
outline should provide an adequate background for easy appli-
cation of CAM ideas to the detail of practical CAM work in
public health, clinical and medical practice, and yet not stray
far away from the very biology that underpins it. CAM is
organismic, inclusive and not exclusive. This organismic
approach involving the cells, tissues, organs and the molecules
that they synthesize and secrete has fostered and indeed uncov-
ered an incredible systemic amalgam, discovering almost daily
an infinite array of new connections and interconnections,
revealing ever more minute complexities almost to the point of
incomprehension—as vast as the universe.
Effective Compounds from a Pivotal Marine
Group: the Sponge as Paradigm
According to Müller et al., nature, especially the marine envi-
ronment, provides the most effective drugs used in human ther-
apy (6). Among the metazoans, the marine sponges (phylum
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Email: ecam@mediet.ucla.eduPorifera), which are sessile filter feeders, produce the most
potent and highly selective bioactive secondary metabolites.
These animals (or their associated symbiotic microorganisms)
synthesize secondary metabolites whose activity and selectivity
have developed during their long evolutionary history
(evochemistry). Pharmaceuticals prepared from marine ani-
mals, primarily sponges, have been applied since ancient times
(Hippocrates, Aristotle and later Plenius). It has been reported
that extracts and/or components from sponges can be used
for the treatment of specific diseases. For a systematic and
applied-oriented exploitation, the successful development of
effective compounds largely depends on the quality of the
institutional infrastructure of marine stations and more so on
the biodiversity.
It is now established that the basic structural and functional
elements are highly conserved from sponges to the crown 
taxa with the Protostomia (Drosophila melanogaster and
Caenorhabditis elegans) and Deuterostomia (human) (13);
therefore, it is obvious that the molecular etiology of diseases
within the metazoan animals may have a common basis (7).
Hence, the major challenge for scientists analyzing natural
product chemistry is to elucidate the target(s) of a particular
secondary metabolite that is per se highly active and selective.
After this step, the potential clinical application can be
approached. Examples of compounds that are already in medical
use [inhibition of tumor/virus growth (arabinofuranosyl cyto-
sine and arabinofuranosyl adenine)], or are being considered
as lead structures [acting as cytostatic and anti-inflammatory
secondary metabolites (avarol/avarone), causing induction of
apoptosis (sorbicillactone)] or as prototypes for the interfer-
ence with metabolic pathways common in organisms ranging
from sponges to humans [modulation of pathways activated by
fungal components (aeroplysinin), inhibition of angiogenesis 
(2-methylthio-1,4-naphthoquinone), immune-modulating activ-
ity (FK506)] are discussed in this study. In addition, bioactive
proteins from sponges are listed [antibacterial activity (pore-
forming protein and tachylectin)]. The goal for the future is to
successfully introduce some of these compounds in the treat-
ment of human diseases in order to raise the public awareness
on the richness and diversity of natural products, which should
be sustainably exploited for human benefit.
Philosophical Underpinning: a Cautionary Note
At the outset, let us get it straight with respect to the growing
position of complementary medicine in the 21st century most
especially in the context of presenting natural products in rela-
tion to CAM. According to Wallis (14) ‘philosophers and sci-
entists often dismiss complementary and alternative medicine
as ‘pseudoscience’. In applying the pseudoscience moniker,
they often intend to suggest that the beliefs and practices of
CAM are as irrational as a fear of flying, as effective as a
rabbit’s foot and as pretentiously deceptive as a mongrel in a
dog show. Many people in Western society have come to think
of science as the deity of reason and pseudoscience is its dop-
pelganger’ (i.e. double). Wallis has portrayed pseudoscientific
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beliefs and practices as resulting from human, but nevertheless
unacceptable, hypotheses, evidence standards and innate
judgment mechanisms. Likewise, science while striving
towards laudable intellectual standards should not be thought
of as an epistemic authority before which one must unthink-
ingly genuflect. Let us beware as we continue this quest.
Actually these points are appropriate in the context of our
resurrection of countless remedies often anecdotal but that are
beginning to gain scientific credence in our search for better
quality of life.
The paradox of all this newer enthusiasm from the West and
historical continuity from Asia prompts a simple explanation.
An amalgamation does occur perhaps across the Pacific as it
were. As the East becomes more affluent, it has tended to
adopt the ways, views and treatments of the West, whereas the
already somewhat more affluent West searches for the wisdom
of the East and begins to embrace attributes associated with
Eastern philosophies and practices. Linkage is reflected in the
bridge on the cover of eCAM, and bioprospecting offers great
possibilities for this linkage. The earthworm, for example, has
long been used, e.g. in Chinese and Ayurvedic medicine for
various ailments, and now as one of the numerous targets of
bioprospecting is coming into Western medicine in the form of
lumbrokinase to treat blood clots (3,8). How far can this bridge
take us? I seriously doubt that in the immediate future an amal-
gam of these philosophies and practices, whether from the East
or the West, will do anything to prevent the inevitable demise
of the organism. However, we do live longer, especially in the
more industrial countries where there is greater access to pub-
lic health care, Western approaches and the increasing accept-
ance of CAM. Yet despite this enormous wealth, there are still
pockets of helplessness internationally that will persist as a
challenge. Nevertheless, we can continue to strive through
prospecting, perhaps knowing full well that we will not find
the true ‘fountain of youth’. In this process of perseverance,
the quality of our limited days on earth [Biosphere I (15)] will
be enhanced considerably and we can and will manage certain
maladies (e.g. diabetes), through newer drug discoveries,
development of certain vaccines and more focused and ana-
lyzed applications of ancient remedies. This is a reasonably
accessible goal for basic scientists and clinicians; CAM can
aid this quest by providing the bridge.
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